Molecular Cloning and Characterization of RGC-32, a Novel Gene Induced by Complement Activation in Oligodendrocytes

This publication has 25 references indexed in Scilit:

• Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway
  Immunopharmacology, 1997
• Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells.
  The Journal of Experimental Medicine, 1994
• Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells.
  Journal of Clinical Investigation, 1993
• Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
  Proceedings of the National Academy of Sciences, 1989
• Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis
  Acta Neuropathologica, 1989
• THE ROLE OF COMPLEMENT IN THE PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
  Brain, 1989
• IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS
  Neuropathology and Applied Neurobiology, 1989
• Normal rat serum cytotoxicity against syngeneic oligodendrocytes
  Journal of the Neurological Sciences, 1989
• Cerebrospinal fluid C9 in demyelinating disease
  Neurology, 1986
• Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.
  Proceedings of the National Academy of Sciences, 1982